Last reviewed · How we verify
NCT06793059: SHIELD
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
NA trial testing SHIELD in Aneurysm in 10 participants. Currently enrolling.
1 January 2027
Quick facts
| Lead sponsor | Jacobs institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 January 2025 |
| Primary completion | 1 January 2027 |
| Estimated completion | 1 January 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SHIELD
Conditions studied
- Aneurysm — all drugs for Aneurysm →
Sponsor
Jacobs institute
Who can join
22 and older, any sex, with Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06793059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SHIELD
Trials testing the same drug.
- NCT02552927 — Chest Shielding in Premature Infants During Phototherapy · NA · completed
Other recruiting trials for Aneurysm
Currently open trials in the same condition.
- NCT06872684 — Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter ( · NA · recruiting
- NCT06689410 — Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms · NA · recruiting
- NCT06235619 — Arch Size Study for Anatomical Variations · recruiting
- NCT06189950 — Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE · NA · recruiting
- NCT05880680 — SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry · recruiting
Other Jacobs institute trials
Trials by the same sponsor.
- NCT07140731 — The Symani Restore Study · NA · recruiting
- NCT06447116 — An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke · NA · active not recruiting
- NCT06411418 — Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm · NA · active not recruiting
- NCT05074186 — Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06793059 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jacobs institute
- Last refreshed: 10 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06793059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing